Related Experiment Video

Updated: May 23, 2025

Human Liver Microphysiological System for Assessing Drug-Induced Liver Toxicity In Vitro
11:06

Human Liver Microphysiological System for Assessing Drug-Induced Liver Toxicity In Vitro

Published on: January 31, 2022

4.3K

Natalizumab-induced autoimmune liver injury

Jeanete S Rodríguez Martínez1, Nancy H Serrano Pérez1, G Espinosa Zarazúa2

  • 1National Autonomous University of Mexico, School of Medicine; Hepatology department, Internal Medicine in Dr. Manuel Gea González General Hospital, Mexico City, Mexico.

Clinics and Research in Hepatology and Gastroenterology
|May 21, 2025
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Induction of Drug-Induced, Autoimmune Hepatitis in BALB/c Mice for the Study of Its Pathogenic Mechanisms
11:36

Induction of Drug-Induced, Autoimmune Hepatitis in BALB/c Mice for the Study of Its Pathogenic Mechanisms

Published on: May 29, 2020

2.9K
Incorporation of a Survivable Liver Biopsy Procedure in Mice to Assess Non-alcoholic Steatohepatitis NASH Resolution
04:14

Incorporation of a Survivable Liver Biopsy Procedure in Mice to Assess Non-alcoholic Steatohepatitis NASH Resolution

Published on: April 16, 2019

11.8K

Related Experiment Videos

Last Updated: May 23, 2025

Human Liver Microphysiological System for Assessing Drug-Induced Liver Toxicity In Vitro
11:06

Human Liver Microphysiological System for Assessing Drug-Induced Liver Toxicity In Vitro

Published on: January 31, 2022

4.3K
Induction of Drug-Induced, Autoimmune Hepatitis in BALB/c Mice for the Study of Its Pathogenic Mechanisms
11:36

Induction of Drug-Induced, Autoimmune Hepatitis in BALB/c Mice for the Study of Its Pathogenic Mechanisms

Published on: May 29, 2020

2.9K
Incorporation of a Survivable Liver Biopsy Procedure in Mice to Assess Non-alcoholic Steatohepatitis NASH Resolution
04:14

Incorporation of a Survivable Liver Biopsy Procedure in Mice to Assess Non-alcoholic Steatohepatitis NASH Resolution

Published on: April 16, 2019

11.8K

Related Concept Videos

Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

1.1K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.1K

Articles linked to this work by shared authors, journal, and citation graph.

Long-term mortality trends of pancreatic cancer and its comorbidities with diabetes mellitus and metabolic disorders, 1999-2023.

Clinics and research in hepatology and gastroenterology·2026

Gene-environment interaction between heavy alcohol use and PNPLA3 rs738409 in incident cirrhosis: Evidence from a diverse U.S. cohort.

Clinics and research in hepatology and gastroenterology·2026

Management of portal vein thrombosis in cirrhosis: Risks, treatments, and outcomes of a retrospective multicenter study with over 10 years of follow-up.

Clinics and research in hepatology and gastroenterology·2026

Safety and effectiveness of GLP-1 receptor agonists and SGLT-2 inhibitors in liver transplant recipients with diabetes.

Clinics and research in hepatology and gastroenterology·2026

Efficacy and safety of empagliflozin in metabolic dysfunction-associated steatotic liver disease: A systematic review and meta-analysis.

Clinics and research in hepatology and gastroenterology·2026

Squamous cell anal carcinoma: Current therapeutic approaches.

Clinics and research in hepatology and gastroenterology·2026

B-cell depletion therapy in systemic lupus erythematosus: emerging strategies and challenges.

Expert opinion on biological therapy·2026

68Ga-FAPI PET/CT for assessing fibroblast activation and disease activity in primary Sjögren's disease: a prospective case-control study.

Rheumatology (Oxford, England)·2026

Rheumatoid arthritis flares and de novo inflammatory arthritis after immune checkpoint inhibitor therapy: a single-center exploratory study of clinical phenotypes.

Immunological medicine·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us